Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion.
about
Is insulin an endogenous cardioprotector?Addressing the Global Burden of Trauma in Major SurgeryCardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.Bench to bedside: tumor necrosis factor-alpha: from inflammation to resuscitation.M3 subtype of muscarinic acetylcholine receptor promotes cardioprotection via the suppression of miR-376b-5p.Emerging therapeutic targets in nitric oxide-dependent cardiac disease.Physiological and pathophysiological aspects of ceramide.Anti-tumour necrosis factor-alpha therapy in heart failure: future directions.Membrane raft redox signalosomes in endothelial cellsRegulation of monocyte induced cell migration by the RNA binding protein, FXR1.Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.Insulin preconditioning elevates p-Akt and cardiac contractility after reperfusion in the isolated ischemic rat heart.Biventricular cardiac dysfunction after acute massive pulmonary embolism in the rat.Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries.A novel function of insulin in rat dermis.Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-alpha.Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
P2860
Q24797044-86CA108E-5E88-47A8-ABFE-5E99DB564A08Q26782817-A445620E-B3DD-4BC0-9EA3-0CA57BDA0678Q30442968-377BEED9-28A9-41E8-A95D-4545B7D9DDB8Q31393590-A9BB1BAE-C159-4F45-B97B-0EBF6537C121Q34013294-D255FFD7-A794-4000-8805-CE440B8BEDF5Q34187234-7977EDE0-5B62-4894-A239-B60326C86F0AQ35050418-50CF6B08-7BD0-4710-BD51-3B7B00AED6C4Q36341274-BA1DE1A8-7449-4204-9C9B-ACA41C1D7354Q36684042-417DF12C-D99B-420E-8CEB-4F3B4940C46FQ37118254-A9048169-E86B-47ED-A6E2-99C017A5D7ECQ38292326-378124B6-3F32-40E0-8134-45B0AF1C978BQ41824383-51BC4147-25FD-4AE9-89BA-84B7124FD3C9Q42180970-99BD7549-84EA-486D-9AEF-87320B260A63Q42502720-5DDC650E-81DC-4E21-837B-F5FA827D47A8Q44182978-710AE118-9ACA-40D0-9691-F4758A50BF80Q44964658-443022E5-45F9-483C-B277-EDDADC77782EQ51360555-6C7274A9-0A21-47F6-8C48-0A4904310E1BQ57374682-17415FF0-962C-4344-9FEB-3BBCE3C68BCB
P2860
Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Therapeutic strategies to redu ...... wing ischemia and reperfusion.
@ast
Therapeutic strategies to redu ...... wing ischemia and reperfusion.
@en
type
label
Therapeutic strategies to redu ...... wing ischemia and reperfusion.
@ast
Therapeutic strategies to redu ...... wing ischemia and reperfusion.
@en
prefLabel
Therapeutic strategies to redu ...... wing ischemia and reperfusion.
@ast
Therapeutic strategies to redu ...... wing ischemia and reperfusion.
@en
P2093
P356
P1476
Therapeutic strategies to redu ...... wing ischemia and reperfusion.
@en
P2093
P304
P356
10.1006/JMCC.1999.0924
P577
1999-05-01T00:00:00Z